What is a FIGO (International Federation of Gynecology and Obstetrics) class 4 uterine leiomyoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FIGO Class 4 Myoma Definition

A FIGO Class 4 uterine leiomyoma (fibroid) is an intramural fibroid where less than 50% of the mass extends into the endometrial cavity (submucosal component), with the majority remaining within the myometrial wall. 1, 2

Understanding the FIGO Classification System

The International Federation of Gynecology and Obstetrics (FIGO) developed a standardized classification system to uniformly describe uterine fibroids based on their anatomic relationship to the endometrium, myometrium, and uterine serosa 3, 1. This classification is essential for:

  • Treatment planning and surgical approach selection
  • Predicting therapeutic responses
  • Preventing complications
  • Standardizing communication between providers

Specific Characteristics of Type 4 Fibroids

Type 4 fibroids are intramural masses with a submucosal component comprising <50% of the total fibroid volume 1, 2. Key features include:

  • Primary location: Within the myometrial wall (intramural)
  • Endometrial cavity involvement: Less than half of the fibroid protrudes into the uterine cavity
  • Distinguishing feature: The majority of the mass (>50%) remains embedded in the myometrium

This contrasts with:

  • Type 3: Intramural with ≥50% submucosal extension
  • Type 5: Entirely intramural with no cavity involvement
  • Types 0-2: Predominantly or entirely submucosal

Clinical Significance

Type 4 fibroids occupy a transitional position between predominantly submucosal (Types 0-3) and purely intramural (Type 5) fibroids 1, 2. Their clinical behavior and treatment approach depend on:

  • The degree of endometrial cavity distortion
  • Associated symptoms (abnormal uterine bleeding, bulk symptoms)
  • Patient fertility goals
  • Size and number of concurrent fibroids

Important caveat: While Type 4 fibroids have submucosal extension, research indicates that abnormal uterine bleeding associated with FIGO Type 4-7 leiomyomas is related to factors other than vascular density alone 4. The mechanism of bleeding is multifactorial and not solely dependent on the degree of cavity involvement.

Diagnostic Approach

Ultrasound should be the first-line imaging modality for diagnosing and classifying uterine fibroids 3, 5. However, MRI is superior for accurate FIGO classification, particularly when:

  • Multiple fibroids are present
  • Surgical planning is required
  • Ultrasound findings are equivocal
  • Precise anatomic mapping is needed 3, 1, 6

MRI provides high-resolution, multiplanar visualization that allows more accurate assessment of the relationship between the fibroid and the endometrial cavity—critical for distinguishing Type 4 from Types 3 and 5 1, 6.

Treatment Implications

The FIGO classification directly influences management decisions 7, 5:

  • Hysteroscopic myomectomy: Generally reserved for Types 0-2; may be technically feasible for some Type 3 fibroids but challenging for Type 4 due to limited intracavitary component 7
  • Laparoscopic or abdominal myomectomy: More appropriate for Type 4 fibroids when fertility preservation is desired 5
  • Uterine artery embolization (UAE): Appropriate option for Type 4 fibroids in properly selected patients 7, 8
  • Medical management: Can be considered regardless of FIGO type when symptoms are mild 5

Critical point: Accurate FIGO classification on imaging reports is mandatory for appropriate treatment selection and surgical planning 3, 1. Radiologists should explicitly state the FIGO type in structured reports to guide clinical decision-making.

References

Research

Diagnosis and classification of uterine fibroids.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2025

Research

The assessment of the relationship between the vascularity of FIGO Type 4-7 leiomyomas and abnormal uterine bleeding.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2022

Research

Guideline No. 461: The Management of Uterine Fibroids.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2025

Research

Smooth Muscle Tumors of the Uterus at MRI: Focus on Leiomyomas and FIGO Classification.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2023

Guideline

acr appropriateness criteria® management of uterine fibroids: 2023 update.

Journal of the American College of Radiology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.